JPH01144982A - Production of unsaturated fatty acid and derivative thereof - Google Patents
Production of unsaturated fatty acid and derivative thereofInfo
- Publication number
- JPH01144982A JPH01144982A JP62300057A JP30005787A JPH01144982A JP H01144982 A JPH01144982 A JP H01144982A JP 62300057 A JP62300057 A JP 62300057A JP 30005787 A JP30005787 A JP 30005787A JP H01144982 A JPH01144982 A JP H01144982A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- unsaturated fatty
- fatty acid
- derivatives
- fatty acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 31
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 13
- 229930195729 fatty acid Natural products 0.000 claims abstract description 13
- 239000000194 fatty acid Substances 0.000 claims abstract description 13
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 13
- 241000316848 Rhodococcus <scale insect> Species 0.000 claims abstract description 12
- 239000008103 glucose Substances 0.000 claims abstract description 12
- 229940024606 amino acid Drugs 0.000 claims abstract description 10
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 229910052751 metal Inorganic materials 0.000 claims abstract description 10
- 239000002184 metal Substances 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 9
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 8
- 235000019157 thiamine Nutrition 0.000 claims abstract description 7
- 239000011721 thiamine Substances 0.000 claims abstract description 7
- 241000187562 Rhodococcus sp. Species 0.000 claims abstract description 5
- 229960003495 thiamine Drugs 0.000 claims abstract description 5
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 4
- 229960004441 tyrosine Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- 229960005261 aspartic acid Drugs 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- 229930182821 L-proline Natural products 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229960002429 proline Drugs 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical group CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 claims 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 229930182844 L-isoleucine Natural products 0.000 claims 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 229960002449 glycine Drugs 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 229910052748 manganese Inorganic materials 0.000 claims 1
- 239000011572 manganese Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract description 22
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract description 11
- 235000019341 magnesium sulphate Nutrition 0.000 abstract description 11
- 244000005700 microbiome Species 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 2
- IZFGRAGOVZCUFB-HJWRWDBZSA-N methyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OC IZFGRAGOVZCUFB-HJWRWDBZSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000000243 solution Substances 0.000 description 20
- 239000002609 medium Substances 0.000 description 18
- 229920001817 Agar Polymers 0.000 description 17
- 239000008272 agar Substances 0.000 description 17
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 10
- 229960000344 thiamine hydrochloride Drugs 0.000 description 10
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 10
- 239000011747 thiamine hydrochloride Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000008363 phosphate buffer Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 5
- 229940077731 carbohydrate nutrients Drugs 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000004817 gas chromatography Methods 0.000 description 5
- 150000002430 hydrocarbons Chemical group 0.000 description 5
- -1 tetradecenoic acid Chemical class 0.000 description 5
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 4
- BEKZXQKGTDVSKX-UHFFFAOYSA-N propyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCC BEKZXQKGTDVSKX-UHFFFAOYSA-N 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- GKSSPDWGCUQHBQ-UHFFFAOYSA-N propyl hexadec-2-enoate Chemical compound CCCCCCCCCCCCCC=CC(=O)OCCC GKSSPDWGCUQHBQ-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 102000000665 Acyl-CoA desaturases Human genes 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- SLNMXQJVKXKDCV-UHFFFAOYSA-N propan-2-yl hexadec-2-enoate Chemical compound CCCCCCCCCCCCCC=CC(=O)OC(C)C SLNMXQJVKXKDCV-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- IBYFOBGPNPINBU-UHFFFAOYSA-N tetradecenoic acid Natural products CCCCCCCCCCCC=CC(O)=O IBYFOBGPNPINBU-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- IBYFOBGPNPINBU-OUKQBFOZSA-N trans-2-tetradecenoic acid Chemical compound CCCCCCCCCCC\C=C\C(O)=O IBYFOBGPNPINBU-OUKQBFOZSA-N 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Chemical class 0.000 description 1
- 239000011782 vitamin Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は微生物を用いる不飽和脂肪酸およびその誘導体
の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing unsaturated fatty acids and derivatives thereof using microorganisms.
不飽和脂肪酸およびその誘導体は、香料、薬剤、塗料、
界面活性剤、化粧品等として、またこれらの合成原料と
して広(使用されている。Unsaturated fatty acids and their derivatives are used in fragrances, drugs, paints,
It is widely used as a surfactant, cosmetics, etc., and as a raw material for their synthesis.
従来、斯かる不飽和脂肪酸およびその誘導体は、動物性
または植物性の油脂を加水分解する方法、あるいは、化
学合成する方法が知られている。Conventionally, such unsaturated fatty acids and their derivatives have been produced by hydrolyzing animal or vegetable oils or by chemically synthesizing them.
しかしながら、油脂を加水分解する方法は、炭素鎖長の
異なる多種多様のものが生成され、また化学合成では多
工程を要するとともに、シス体とトランス体の立体異性
体が混合状態で得られ、いずれの方法も分離が困難であ
るという欠点があった。However, the method of hydrolyzing fats and oils produces a wide variety of products with different carbon chain lengths, and chemical synthesis requires multiple steps, and a mixture of cis and trans stereoisomers is obtained. This method also had the disadvantage that separation was difficult.
一方、不飽和脂肪酸製造において微生物を利用する方法
としては、特公昭61−37096号のタムニブイウム
属菌を用いるT−リルン酸醗酵、特公昭58−2219
9号のモルティエラ属菌をめ、その回収が困難であると
いう欠点があった。On the other hand, methods of utilizing microorganisms in the production of unsaturated fatty acids include T-lilunic acid fermentation using Tamnibuium spp. described in Japanese Patent Publication No. 61-37096, and Japanese Patent Publication No. 58-2219.
The problem was that it contained Mortierella bacteria No. 9 and was difficult to recover.
脂肪酸誘導体を不飽和化する酵素として、微生物、動物
、植物由来の酵素としてアシルCoA不飽和化酵素(^
cyl−Co八desatへrase、 E、C,1,
14,99゜5)等が知られているが、酵素活性が低く
、かつ非常に不安定で、工業生産には適していない。Acyl-CoA desaturase (^) is an enzyme derived from microorganisms, animals, and plants that desaturates fatty acid derivatives.
cyl-Co eight desat, E, C, 1,
14,99°5) are known, but they have low enzymatic activity and are extremely unstable, making them unsuitable for industrial production.
また、本発明者らは、特願昭62−33363号におい
てロドコッカス(Rhodococcus)属に属する
不飽和脂肪酸生産菌を利用して不飽和脂肪酸等を製造す
る方法を報告したが、該方法を用いた場合、生産量が未
だ十分とはいえず、工業的生産性を十分に満足するもの
とはいえなかった。In addition, the present inventors reported a method for producing unsaturated fatty acids etc. using an unsaturated fatty acid producing bacterium belonging to the genus Rhodococcus in Japanese Patent Application No. 62-33363; In this case, the production volume was still not sufficient, and it could not be said that industrial productivity was fully satisfied.
斯かる現状において、本発明者らは鋭意研究を行った結
果、土壌から分離し、さらに参考例1に示すような変異
操作を行って得られた微生物が脂肪酸およびその誘導体
を不飽和脂肪酸およびその誘導体に変換する能力を有す
ること、ならびに生産された不飽和脂肪酸およびその誘
導体は菌体外に排出され、容易に回収できることを見出
した。Under these circumstances, the present inventors conducted intensive research and found that microorganisms isolated from soil and further mutated as shown in Reference Example 1 were able to transform fatty acids and their derivatives into unsaturated fatty acids and their derivatives. It has been found that the unsaturated fatty acids and their derivatives produced are excreted outside the bacterial cells and can be easily recovered.
または硫酸マグネシウム、硫酸マンガン等の無機金属塩
を添加することにより不飽和脂肪酸およびその誘導体の
生産性を大幅に向上させることを見出し本発明を完成し
た。Alternatively, the present invention was completed by discovering that the productivity of unsaturated fatty acids and their derivatives can be greatly improved by adding inorganic metal salts such as magnesium sulfate and manganese sulfate.
すなわち本発明は、ロドコッカス属に属する不飽和脂肪
酸生産菌の菌体を用い、炭水化物もしくはアミノ酸存在
下に、脂肪酸またはその誘導体を咳菌体に作用せしめ不
飽和脂肪酸またはその誘導体を製造するに際し、系内に
チアミンまたは無機金属塩を存在させることを特徴とす
る不飽和脂肪酸およびその誘導体の製造法を提供するも
のである。That is, the present invention uses bacterial cells of unsaturated fatty acid-producing bacteria belonging to the genus Rhodococcus to produce unsaturated fatty acids or derivatives thereof by applying fatty acids or derivatives thereof to cough bacterial cells in the presence of carbohydrates or amino acids. The present invention provides a method for producing unsaturated fatty acids and derivatives thereof, characterized in that thiamine or an inorganic metal salt is present therein.
本発明者らが見出した本発明で使用されるロドコッカス
属に属する不飽和脂肪酸生産菌は、参考例1の方法で沖
縄県の土壌より取得した菌株を変異により育種した株で
あり、次の菌学的性質を有する。The unsaturated fatty acid-producing bacterium belonging to the genus Rhodococcus discovered by the present inventors and used in the present invention is a strain bred by mutation of a strain obtained from soil in Okinawa Prefecture by the method of Reference Example 1, and the following bacterium: It has scientific properties.
(A)形態
桿菌で、細胞は多形性で、若い培養では桿菌状、古い培
養では球状となる。大きさは0.5〜0.8 μmX1
.0〜5.0μmである。(A) Morphology: Bacilli; the cells are pleomorphic, becoming rod-shaped in young cultures and spherical in older cultures. Size is 0.5-0.8 μm x 1
.. It is 0 to 5.0 μm.
■グルコース・アスパラギン寒天培地
生育は貧弱であり、コロニーの色は淡い肌色で、滑らか
で光沢がある。■Glucose-asparagine agar medium Growth is poor, and the colonies are pale flesh-colored, smooth and shiny.
■グリセリン・アスパラギン寒天培地
生育は中程度であり、コロニーの色は乳白色で、滑らか
でにぷい光沢がある。スムーズとラフなコロニーが見ら
れる。■Glycerin-asparagine agar medium Growth is moderate, and the colonies are milky-white, smooth and glossy. Smooth and rough colonies can be seen.
■スターチ寒天培地
生育は中程度であり、コロニーの色は乳白色で、滑らか
でにぷい光沢がある。■Growth on starch agar medium is moderate, and the colonies are milky-white, smooth and glossy.
■チロシン寒天培地
生育は旺盛で、コロニーの色は肌色で、滑らかで光沢が
ある。スライム状になるコロニーカ見られる。■Tyrosine agar medium Growth is vigorous, and the colonies are flesh-colored, smooth and shiny. Colony mosquitoes that become slime-like can be seen.
■栄養寒天培地
生育は旺盛で、コロニーの色は淡いオレンジ色で、滑ら
かで光沢がある。スムーズとラフなコロニーが見られる
。■Nutritional agar medium Growth is vigorous, and the colonies are pale orange in color, smooth and glossy. Smooth and rough colonies can be seen.
■イースト・麦芽寒天培地
生育は旺盛で、コロニーの色はオレンジ色で、ンジ色で
、にぶい光沢がある。■Yeast/malt agar medium Growth is vigorous, and colonies are orange to dark brown with a dull luster.
(C)生理学的性質
■生育範囲
温度:15〜37 ’C(最適25〜35°C)PH:
5〜9.5(最適6〜8)
■ゼラチンの液化(グルコース・ペプトン・ゼラチン培
地)
陰性。(C) Physiological properties ■Growth range Temperature: 15-37'C (optimum 25-35°C) PH:
5-9.5 (optimal 6-8) ■ Liquefaction of gelatin (glucose/peptone/gelatin medium) Negative.
■スターチの加水分解(スターチ寒天培地)陰性。■Starch hydrolysis (starch agar medium) negative.
■脱脂牛乳の凝固、ペプトン化 共に陰性。■Coagulation and peptonization of skimmed milk Both tested negative.
■メラニン様色素の生成(チロシン培地、ペプトン・イ
ースト・鉄培地)
陰性。■Melanin-like pigment production (tyrosine medium, peptone/yeast/iron medium) Negative.
(D)炭素源の資化性 ■L−アラビノース + ■D−キシロース + ■D−グルコース + ■D−フラクトース 士 ■D−マンニトール + (Iり化学分類学的性質 ■グリコリルテスト グリコリル型。(D) Assimilation of carbon sources ■L-arabinose + ■D-xylose + ■D-glucose + ■D-fructose ■D-Mannitol + (I chemical taxonomic properties ■Glycolyl test Glycolyl type.
■メナキノン システム MK−8(Hz ) 。■Menaquinone system MK-8 (Hz).
以上の菌学的性質を有する微生物について、バーシーズ
・マニュアル・オプ・システマテイツク・ハタテリオロ
ジ−(Bergey’s Manual ofSyst
ematic Bacteriology)+第2巻(
1986年)に基づき検索した結果、ロドコッカス(R
hodococcus)属に属する菌株と認められたが
、他のロドコッカス属菌と不飽和脂肪酸の生産性の生産
性が著しく異なるため、ロドコッカス・エスピー・KS
M−B−3M (Rhodococcus sp、
KSM−B−3M)と名し、通産省工業技術院微生物
工業技術研究所に微工研条寄第1531号(FERM
BP−1531)として寄託しである。Microorganisms with the above mycological properties are described in Bergey's Manual of Syst.
ematic Bacteriology) + Volume 2 (
As a result of the search based on Rhodococcus (1986), Rhodococcus (R
Although it was recognized as a strain belonging to the genus Rhodococcus, the productivity of unsaturated fatty acids was significantly different from that of other Rhodococcus bacteria, so it was classified as Rhodococcus sp. KS.
M-B-3M (Rhodococcus sp,
KSM-B-3M), and was sent to the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, with the name No. 1531 (FERM).
BP-1531).
本発明方法を実施する際の原料となりうる脂肪酸および
その誘導体としては例えば次の一般式〔式中Rは炭素数
1〜22の直鎖もしくは分岐、飽和もしくは不飽和の炭
化水素基を表し、R1は水素原子、炭素数1〜10の直
鎖もしくは分岐炭化水素基あるいは芳香族炭化水素基、
アルカリ金属または、
(Rz 、Rz は水素原子、もしくは炭素数1〜5の
直鎖もしくは分岐炭化水素基を示す)で表す基を表す、
〕
本発明においては、Rが炭素数14〜20の直鎖の炭化
水素基、R1は炭素数2〜4の直鎖もしくは分岐炭化水
素基のものが好ましく用いられる。Examples of fatty acids and derivatives thereof that can be used as raw materials for carrying out the method of the present invention include the following general formula [wherein R represents a straight chain or branched, saturated or unsaturated hydrocarbon group having 1 to 22 carbon atoms, R1 is a hydrogen atom, a straight chain or branched hydrocarbon group having 1 to 10 carbon atoms, or an aromatic hydrocarbon group,
represents an alkali metal or a group represented by (Rz, Rz represents a hydrogen atom or a straight chain or branched hydrocarbon group having 1 to 5 carbon atoms),
] In the present invention, R is preferably a straight chain hydrocarbon group having 14 to 20 carbon atoms, and R1 is preferably a straight chain or branched hydrocarbon group having 2 to 4 carbon atoms.
そして本発明によれば、上記脂肪酸およびその誘導体は
、対応する不飽和脂肪酸およびその誘導体に変換される
。具体例を示すならば、n−ヘキサデカン酸、n−テト
ラデカン酸等の脂肪酸のメチル、エチル、n−プロピル
、イソプロピル、nテトラデセン酸等の脂肪酸のメチル
、エチル、n本発明において、該菌の菌体を取得するに
は通常の微生物の培養方法によれば良く、培養に際して
は、用いる培地、pH1温度、培養時間等については、
当該菌株が生育すれば、何れの条件でもよい。好ましく
は、30°Cで1〜2日間、好気的に培養する。According to the present invention, the fatty acids and their derivatives are converted into corresponding unsaturated fatty acids and their derivatives. Specific examples include methyl of fatty acids such as n-hexadecanoic acid, n-tetradecanoic acid, ethyl, n-propyl, isopropyl, n-methyl and ethyl of fatty acids such as tetradecenoic acid, To obtain the microorganisms, it is sufficient to use the usual culture method of microorganisms.
Any conditions may be used as long as the strain concerned grows. Preferably, the culture is carried out aerobically at 30°C for 1 to 2 days.
かくして得られた、培養液をそのまま、あるいは遠心分
離または濾過等により菌体を取得し以下の反応に供する
。The culture fluid thus obtained is used as it is, or the bacterial cells are obtained by centrifugation, filtration, etc. and subjected to the following reaction.
菌体を用いた反応液の調製、ならびに反応は以下のごと
く行う。Preparation of a reaction solution using bacterial cells and reaction are performed as follows.
上記の培養液または集めた菌体を0.1〜90%、好ま
しくは菌体乾燥重量として0.2〜0.5%を水あるい
は緩衝液(pH6〜8)に懸濁し、反応させる脂肪酸及
びその誘導体を1〜70%、好ましくは10〜30%、
L−グルタミン酸、L−アスパラギン酸等のアミノ酸ま
たは、ぶどう糖、コハク酸等の炭水化物を0.05〜1
0%、好ましくは0.5〜2%を含有するものを基本反
応液とし、さらに、チアミンの塩酸塩等2%、好ましく
は硫酸マグネシウムを0.01〜0.3%を加え本発明
の反応液とし、20〜37°C1好ましくは25〜30
°Cで、好気条件下で反応を行う。この反応により反応
液中に加えた脂肪酸およびその誘導体に対応する不飽和
脂肪酸およびその誘導体が生成する。The above culture solution or collected bacterial cells are suspended in 0.1 to 90%, preferably 0.2 to 0.5% as dry weight of the bacterial cells, in water or a buffer solution (pH 6 to 8) and reacted with fatty acids and 1 to 70% of the derivative, preferably 10 to 30%,
Amino acids such as L-glutamic acid and L-aspartic acid, or carbohydrates such as glucose and succinic acid, from 0.05 to 1
The basic reaction solution is one containing 0%, preferably 0.5 to 2%, and further 2% of thiamine hydrochloride, preferably 0.01 to 0.3% of magnesium sulfate is added to carry out the reaction of the present invention. liquid, 20-37°C1 preferably 25-30°C
The reaction is carried out under aerobic conditions at °C. This reaction produces unsaturated fatty acids and derivatives thereof corresponding to the fatty acids and derivatives thereof added to the reaction solution.
反応液中の、チアミン、または硫酸マグネシウム等の添
加は、不飽和脂肪酸及びその誘導体の生産性を大幅に向
上させるためであり、L−グルタミン酸、L−アスパラ
ギン酸等のアミノ酸との組合せが好ましいが、他の炭水
化物との組合せや、それぞれ単独でアミノ酸や炭水化物
と組合せて反応してもよい。また、菌体を取得する時に
これらを添加しておいてもよい。The addition of thiamine or magnesium sulfate to the reaction solution is to significantly improve the productivity of unsaturated fatty acids and their derivatives, and combinations with amino acids such as L-glutamic acid and L-aspartic acid are preferred. , may be reacted in combination with other carbohydrates, or individually in combination with amino acids or carbohydrates. Further, these may be added at the time of obtaining the bacterial cells.
チアミンはソルトフリー、塩酸塩、硫酸塩等のいずれの
状態でもよい。無機金属塩としては硫酸マグネシウムが
好ましいが、硫酸マンガン等、硫酸または、マグネシウ
ムあるいはマンガンを含む無機金属塩も用いることがで
きる。Thiamin may be in any state such as salt-free, hydrochloride, sulfate, etc. As the inorganic metal salt, magnesium sulfate is preferred, but sulfuric acid, or inorganic metal salts containing magnesium or manganese, such as manganese sulfate, can also be used.
また、アミノ酸、炭水化物、チアミン、無機金できる。It can also produce amino acids, carbohydrates, thiamin, and inorganic gold.
反応時間は、回分反応を行う場合、1〜3日程度で良い
が、原料となる脂肪酸およびその誘導体、アミノ酸、ビ
タミン、金属塩等を補いながらさらに延長することも可
能である。When performing a batch reaction, the reaction time may be about 1 to 3 days, but it can be extended further by supplementing raw materials such as fatty acids and derivatives thereof, amino acids, vitamins, metal salts, etc.
また、−度使用した菌体を遠心分離、濾過等により回収
し、再反応することも可能である。It is also possible to collect the used bacterial cells by centrifugation, filtration, etc. and re-react them.
反応液中に生成した不飽和脂肪酸およびその誘導体の同
定、定量方法は、通常の天然物に含まれる有機化合物の
同定、定量方法により行われる。The unsaturated fatty acids and their derivatives produced in the reaction solution can be identified and quantified using conventional methods for identifying and quantifying organic compounds contained in natural products.
例えば、反応液の一定量より有機溶剤にて抽出を行った
後、ガスクロマトグラフィー(GC)あるいはガスクロ
マトグラフ・質量分析計(QC−MS)等による分析を
行うことにより、同定、定量することができる。また、
不飽和化合物の二重結合の位置決定には、ジメチルジス
ルフィド処理後、GC−MS分析を行うメチルチオエー
テル化法〔2原ら、油化学 34巻 619頁(198
5年)他〕等が利用できる。For example, identification and quantification can be performed by extracting a certain amount of the reaction solution with an organic solvent and then analyzing it using gas chromatography (GC) or gas chromatograph/mass spectrometer (QC-MS). can. Also,
To determine the position of the double bond in an unsaturated compound, the methylthioetherification method, which involves GC-MS analysis after treatment with dimethyl disulfide [2 Hara et al., Oil Chemistry Vol. 34, p. 619 (198
5 years) and others] are available.
反応液中に生成した不飽和脂肪酸およびその誘しくは濾
過等により菌体を除去した後、有機溶剤で抽出すること
により、橿めて簡便に目的物を回収できる。また、さら
に精製する必要のある場合は、通常のカラムクロマトグ
ラフィー、分配抽出などにより精製・単離が可能である
。After removing the unsaturated fatty acid produced in the reaction solution and, preferably, the bacterial cells by filtration or the like, the desired product can be easily recovered by extraction with an organic solvent. In addition, if further purification is required, purification and isolation can be carried out by ordinary column chromatography, partition extraction, etc.
本発明によれば、ロドコッカス属に属する不飽和脂肪酸
生産菌の菌体を使用して不飽和脂肪酸およびその誘導体
を工業的に有利に製造することができる。According to the present invention, unsaturated fatty acids and derivatives thereof can be advantageously produced industrially using cells of unsaturated fatty acid producing bacteria belonging to the genus Rhodococcus.
次に実施例を挙げて説明する。 Next, an example will be given and explained.
実施例1
グルコース2.5g、ポリペプトン〔大玉栄養(株)製
〕 17g、ポリペプトンS〔大玉栄養(株)製)3g
、リン酸2水素1カリウム2.5g、塩化ナトリウム5
gおよびイオン交換水12よりなる培地50m2を入れ
た500mj!容坂ロフラスコにロドコッカス・エスピ
ー・KSM−Bの培養液を5000x工で遠心分離を行
い菌体2gを得た。菌体1gを1%グルタミン酸モノナ
トリウム、0.1%チアミン塩酸塩、0.1%硫酸マグ
ネシウムを含む0.25Mリン酸緩衝液(pH7,0)
20mffiにQ、 33し、バルミチン酸プロピル(
Palmitic acid n−propyl es
ter。Example 1 2.5 g of glucose, 17 g of polypeptone (manufactured by Otama Nutrition Co., Ltd.), 3 g of polypeptone S (manufactured by Otama Nutrition Co., Ltd.)
, 1 potassium dihydrogen phosphate 2.5 g, 5 sodium chloride
500 mj containing 50 m2 of culture medium consisting of g and 12 ml of ion-exchanged water! A culture solution of Rhodococcus sp. KSM-B was centrifuged at 5000x in a Yosaka Rof flask to obtain 2 g of bacterial cells. 1 g of bacterial cells was added to 0.25M phosphate buffer (pH 7.0) containing 1% monosodium glutamate, 0.1% thiamine hydrochloride, and 0.1% magnesium sulfate.
Q, 33 to 20 mffi, propyl balmitate (
Palmitic acid n-propyl es
ter.
propyl hexadecanoate) 4
m lを加え、500m2容坂ロフラスコ中で26°C
で2日間振盪し反応を行った。propyl hexadecanoate) 4
ml and heated at 26°C in a 500 m2 Slope flask.
The reaction was carried out by shaking for 2 days.
反応後、反応液に含まれる主生成物を酢酸エチルで抽出
し、ガスクロマトグラフィー(GC)、ガスクロマトグ
ラフ・’RM分析計(GC−MS)あるいはガスクロマ
トグラフ・赤外分析計(GC−FT−I R)による分
析(図1)を行い、主生成物がシス−6−ヘキサデセン
酸プロピル(propyl cis−6−hexade
cenoate)であることを確認した。なお、二重結
合の位置決定はジメチルジスルフィド誘導体化後、マス
スペクトルの解析により行った(図2)。主生成物のマ
ススペクトルβ・2日間の生産性であった。After the reaction, the main product contained in the reaction solution is extracted with ethyl acetate and subjected to gas chromatography (GC), gas chromatograph/RM analyzer (GC-MS), or gas chromatograph/infrared analyzer (GC-FT-). IR) analysis (Figure 1) was performed, and the main product was propyl cis-6-hexadenoate.
cenoate). The position of the double bond was determined by mass spectrum analysis after dimethyl disulfide derivatization (FIG. 2). The mass spectrum β of the main product was the productivity for 2 days.
実施例2
実施例1のバルミチン酸プロピルの代わりに、バルミチ
ン酸メチル(methyl hexadecanoat
e)、バルミチン酸エチル(ethyl hexade
canoate)、バルミチン酸イソプロピル(iso
−propyl hexadeca−noa te)、
バルミチン酸イソブチル(1so−butylhexa
decanoa te)、バルミチン酸ブチル(n−b
utylhexadecanoa te)を用いた以外
は実施例1と同様の操作を行い、反応させた。Example 2 Methyl hexadecanoat was used instead of propyl balmitate in Example 1.
e), ethyl hexade
canoate), isopropyl valmitate (iso
-propyl hexadeca-noate),
Isobutyl valmitate (1so-butylhexa
decanoate), butyl valmitate (n-b
The reaction was carried out in the same manner as in Example 1 except that util hexadecanoate) was used.
反応液中の不飽和脂肪酸エステルを実施例1と同様の操
作により同定・定量を行ったところ、下記表−1に示す
如き結果を得た。When the unsaturated fatty acid ester in the reaction solution was identified and quantified in the same manner as in Example 1, the results shown in Table 1 below were obtained.
以下余白
実施例3
実施例1のパルミチン酸プロピルの代わりに、バルミチ
ン酸ナトリウム、ミリスチン酸イソプロピル、ミリスチ
ン酸エチルを用いた以外は実施例1と同様の操作を行い
、反応させた。Example 3 The same procedure as in Example 1 was performed except that sodium valmitate, isopropyl myristate, and ethyl myristate were used in place of propyl palmitate in Example 1 to cause a reaction.
以下余白
比較例1
グルコース2.5g、ポリペプトン17g、ポリペプト
ンS3g、リン酸2水素1カリウム2.5g、塩化ナト
リウム5gおよびイオン交換水1Nよりなる培地50m
2を入れた500mj!容坂ロフラスコにロドコッカス
・エスピー・KSM−B−3M株を移植し、30°Cに
て1日間振盪培養を行った。後、この培養液1mff1
を同じ組成の培地100mlを入れた5 00mf容坂
ロフラスコに移植し、30°Cにて1日間振盪壇養を行
った。この培養液を5000X工で遠心分離を行いで2
日間振盪し反応を行った。Comparative Example 1: 50 m of culture medium consisting of 2.5 g of glucose, 17 g of polypeptone, 3 g of polypeptone S, 2.5 g of monopotassium dihydrogen phosphate, 5 g of sodium chloride, and 1N of ion-exchanged water
500mj including 2! Rhodococcus sp. KSM-B-3M strain was transplanted into a Yosaka Rof flask and cultured with shaking at 30°C for 1 day. After that, this culture solution 1mff1
were transplanted into a 500 mf Yosaka flask containing 100 ml of a medium with the same composition, and cultured with shaking at 30°C for 1 day. This culture solution was centrifuged at 5000X for 2
The reaction was carried out by shaking for several days.
反応液1m2を酢酸エチル3mj2で抽出し、ヘキサデ
セン酸イソプロピルを実施例1と同様の操作により、同
定・定量を行ったところ、4.0g/2・2日間の生産
性であった。1 m2 of the reaction solution was extracted with 3 mj2 of ethyl acetate, and isopropyl hexadecenate was identified and quantified in the same manner as in Example 1, and the productivity was 4.0 g/2.2 days.
比較例2
比較例1の1.0%グルコースを含む0.25Mリン酸
緩衝液の代わりに1.0%L−グルタミン酸モノナトリ
ウムを含む0.25MUン酸緩衝液を用いた以外は比較
例1と同様の方法で反応させた。Comparative Example 2 Comparative Example 1 except that 0.25 MU phosphate buffer containing 1.0% monosodium L-glutamate was used instead of the 0.25 M phosphate buffer containing 1.0% glucose in Comparative Example 1. The reaction was carried out in the same manner.
反応液中のへキサデセン酸イソプロピルのtを実施例1
と同様の操作により、同定・定量を行ったところ、5.
2g/l・2日間の生産性であった。Example 1
Identification and quantification were performed using the same procedure as in 5.
The productivity was 2 g/l for 2 days.
実施例4
比較例1の1.0%グルコースを含む0.25Mリン酸
緩衝液の代わりに
01.0%グルコース、0.1%チアミン塩酸塩酸緩衝
液
■1.0%L−グルタミン酸モノナトリウム、0.1%
チアミン塩酸塩を含む0.25Mリン酸緩衝液、
■1.0%L−グルタミン酸モノナトリウム、0.1%
チアミン塩酸塩、0.1%硫酸マグネシウムを含む0.
25MIJン酸緩衝液、■1.0%L−アスパラギン酸
モノナトリウム、0.1%チアミン塩酸塩、0.1%硫
酸マグネシウムを含む0.25MIJン酸緩衝液、01
.0%グリシン、0.1%チアミン塩酸塩を含む0.2
5Mリン酸緩衝液、
■1.0%L−チロシン、0.1%チアミン塩酸塩、0
.1%硫酸マグネシウムを含む0.25Mリン酸緩衝液
、
■1.0%L−スレオニン、0.1%チアミン塩酸塩、
0.1%硫酸マグネシウムを含む0.25Mリン酸緩衝
液、
■1.0%L−プロリン、0.1%チアミン塩酸塩、0
.1%硫酸マグネシウムを含む0.25M衝液をそれぞ
れ用いた以外は比較例1と同様の方法で反応させた。Example 4 Instead of the 0.25M phosphate buffer containing 1.0% glucose in Comparative Example 1, 01.0% glucose, 0.1% thiamine hydrochloride acid buffer ■ 1.0% monosodium L-glutamate, 0.1%
0.25M phosphate buffer containing thiamine hydrochloride, ■1.0% monosodium L-glutamate, 0.1%
Thiamine hydrochloride, 0.1% magnesium sulfate.
25 MIJ acid buffer, ■ 0.25 MIJ acid buffer containing 1.0% monosodium L-aspartate, 0.1% thiamine hydrochloride, 0.1% magnesium sulfate, 01
.. 0.2 containing 0% glycine, 0.1% thiamine hydrochloride
5M phosphate buffer, ■1.0% L-tyrosine, 0.1% thiamine hydrochloride, 0
.. 0.25M phosphate buffer containing 1% magnesium sulfate, ■1.0% L-threonine, 0.1% thiamine hydrochloride,
0.25M phosphate buffer containing 0.1% magnesium sulfate, ■1.0% L-proline, 0.1% thiamine hydrochloride, 0
.. The reaction was carried out in the same manner as in Comparative Example 1, except that a 0.25M solution containing 1% magnesium sulfate was used.
反応液中の不飽和脂肪酸エステルを実施例1と同様の操
作により同定・定量を行ったところ、下記表−3に示す
如き結果を得た。When the unsaturated fatty acid ester in the reaction solution was identified and quantified in the same manner as in Example 1, the results shown in Table 3 below were obtained.
以下余白
参考例1
採取した沖縄県の土壌サンプル約0.5gを滅液体培地
(I):
n−ヘキサデカン 100g
(N114)2SO420g
Kll□Pop 20 g酵母エ
キス 2g
門gso、・ 711□OO,5g
FeSO4・7LOo、ot g
MnSO−・4〜6LOO,008g
イオン交換水 II!。Reference example 1: Approximately 0.5 g of the collected soil sample from Okinawa Prefecture was placed in a sterile liquid medium (I): n-hexadecane 100 g (N114)2SO4 20 g Kll□Pop 20 g Yeast extract 2 g Gso, 711□OO, 5 g FeSO4・7LOo,ot g MnSO-・4~6LOO,008g Ion exchange water II! .
pH7
上記培養により増殖を示した培養液を滅菌水により適度
に希釈した後、普通寒天培地(栄研化学製)に移植して
30°Cにて2日間培養し、生じた複数のコロニーが相
互間に相違しないことを肉眼的および顕微鏡的に確認で
きるまで、普通寒天培地への移植を繰り返した。pH 7 After appropriately diluting the culture solution that showed growth in the above culture with sterilized water, it was transferred to an ordinary agar medium (manufactured by Eiken Chemical Co., Ltd.) and cultured at 30°C for 2 days. The transplantation to the ordinary agar medium was repeated until it was confirmed macroscopically and microscopically that there was no difference between the two.
本分離菌株を0.1MIJン酸緩衝液(pH7,0)に
懸濁し、紫外線を90秒間照射した。This isolated bacterial strain was suspended in 0.1 MIJ acid buffer (pH 7.0) and irradiated with ultraviolet light for 90 seconds.
そのあと取得したコロニーをグルコース2.5g、30
°Cにて1日間振盪培養を行った。この培養液から遠心
分離により得た菌体を0.5%グルコースを含む0.2
5Mリン酸緩衝液(pH7,0)19m2に懸濁し、ヘ
キサデカン1mfを加え、500mj2容坂ロフラスコ
中で30°Cで3日間振盪した。振盪後、反応液に含ま
れる主生成物を抽出し、ガスクロマトグラフィー(CC
)等による分析を行い、ヘキサデセンを生産する菌株に
ついて取得した。After that, the obtained colonies were treated with 2.5 g of glucose and 30 g of glucose.
Shaking culture was performed at °C for 1 day. Bacterial cells obtained from this culture solution by centrifugation were added to 0.2 μg containing 0.5% glucose
The suspension was suspended in 19 m2 of 5M phosphate buffer (pH 7,0), 1 mf of hexadecane was added, and the mixture was shaken at 30°C for 3 days in a 500 mj 2-volume Slope flask. After shaking, the main product contained in the reaction solution was extracted and subjected to gas chromatography (CC
), etc., and strains that produce hexadecene were obtained.
このヘキサデセンを生産する菌株を滅菌水により適度に
希釈した後、普通寒天培地に移植して30°Cにて2日
間培養し、生じた複数のコロニーが相互間に相違しない
ことを肉眼的および顕微鏡的に確認できるまで、普通寒
天培地への移植を繰り返した。After appropriately diluting this hexadecene-producing strain with sterilized water, it was transferred to an ordinary agar medium and cultured at 30°C for 2 days, and it was confirmed visually and microscopically that the resulting colonies were not different from each other. The transplantation to ordinary agar culture medium was repeated until confirmation was made.
その後、普通寒天培地に生育してきたコロニーのうち、
10個のコロニーをそれぞれ、下記組成の斜面寒天培地
(II)に接種し、30°Cにて3日間培養し、10本
の斜面寒天培地上の菌株が肉眼的および顕微鏡的に同一
菌株であること、およびn−ヘキサデカン
20 g(NHa)*SOn 20
gKH2POn 2 g酵母
エキス 2g
Mg5Oa・ 7HzOO,5g
FeSOa ・7thOO,01g
MnSO4・4〜6tlzOO,008gポリオキシエ
チレン−
ソルビタンモノラウリン酸 0.05 gエステル(
平均付加EO数20モル)
寒天 20 g
イオン交換水 IP
次いで、上記操作により得られた菌株について、斜面寒
天培地から一白金耳を、滅菌した10%グリセリン水溶
液(2rr+42)の入った凍結保存用のバイアルに懸
濁し一80゛cにて凍結保存した。After that, among the colonies that grew on ordinary agar medium,
Each of the 10 colonies was inoculated onto an agar slant (II) with the following composition and cultured at 30°C for 3 days, and the strains on the 10 agar slants were macroscopically and microscopically the same strain. and n-hexadecane
20 g(NHa)*SOn 20
gKH2POn 2g yeast extract 2g Mg5Oa・7HzOO,5g FeSOa・7thOO,01g MnSO4・4~6tlzOO,008g polyoxyethylene-sorbitan monolauric acid 0.05g ester (
Average added EO number: 20 moles) Agar: 20 g Ion-exchanged water: IP Next, for the bacterial strain obtained by the above procedure, a loopful of it was taken from the slanted agar medium and placed in a cryopreservation solution containing a sterilized 10% glycerin aqueous solution (2rr+42). The suspension was suspended in a vial and stored frozen at -80°C.
斯くして3ケ月保存後、迅速に解凍して得られる懸濁液
の一白金耳を寒天培地で蘇生後、前記と状および生理学
的性質を調べたが、変化は認められなかった。After 3 months of storage, a loopful of the suspension obtained by rapid thawing was resuscitated on an agar medium, and the above-mentioned shape and physiological properties were examined, but no changes were observed.
なお、本菌株の各堵地上での性状および生理学的性質は
前述したとおりである。The properties and physiological properties of this strain on each soil are as described above.
図1に本発明により製造したヘキサデセン酸プロピルの
GC−FT−I Rによるスペクトルを示した。
図2に本発明により製造したヘキサデセン酸プロピルの
ビスメチルチオエーテル1H4Cのマススペクトルを示
した。
図3に本発明により製造したヘキサデセン酸プロピルの
マススペクトルを示した。
以上FIG. 1 shows a GC-FT-IR spectrum of propyl hexadecenoate produced according to the present invention. FIG. 2 shows the mass spectrum of propyl hexadecenate bismethylthioether 1H4C produced according to the present invention. FIG. 3 shows the mass spectrum of propyl hexadecenoate produced according to the present invention. that's all
Claims (1)
を用い、炭水化物もしくはアミノ酸存在下に、脂肪酸ま
たはその誘導体を該菌体に作用せしめ不飽和脂肪酸また
はその誘導体を製造するに際し、系内にチアミンまたは
無機金属塩を存在させることを特徴とする不飽和脂肪酸
およびその誘導体の製造法。 2、不飽和脂肪酸生産菌がロドコッカス・エスピー・K
SM−B−3M株である特許請求の範囲第1項記載の製
造法。 3、炭水化物がグルコース、ソルビトール、アラビノー
ス、キシロース、フラクトース、イノシトール、ラムノ
ース、マンニトール、酢酸、コハク酸、クエン酸である
特許請求の範囲第1項記載の製造法。 4、アミノ酸がL−グルタミン酸、L−アスパラギン酸
、グリシン、L−スレオニン、L−チロシン、L−イソ
ロイシン、L−プロリンである特許請求の範囲第1項記
載の製造法。 5、無機金属塩が、硫酸またはマグネシウムあるいはマ
ンガンを含む無機金属塩である特許請求の範囲第1項記
載の製造法。 6、脂肪酸またはその誘導体がn−ヘプタデカン酸、n
−ヘキサデカン酸、n−ペンタデカン酸、n−テトラデ
カン酸、またはそのメチル、エチル、n−プロピル、イ
ソプロピル、n−ブチル、イソブチル、ターシャリィブ
チル、n−ヘプチル、n−ヘキシルの各エステルからな
る群より選ばれたものである特許請求の範囲第1項記載
の製造法。[Scope of Claims] 1. Production of unsaturated fatty acids or derivatives thereof by using bacterial cells of unsaturated fatty acid-producing bacteria belonging to the genus Rhodococcus and allowing fatty acids or derivatives thereof to act on the bacterial cells in the presence of carbohydrates or amino acids. 1. A method for producing unsaturated fatty acids and derivatives thereof, characterized in that thiamine or an inorganic metal salt is present in the system. 2. The unsaturated fatty acid producing bacterium is Rhodococcus sp.
The production method according to claim 1, which is the SM-B-3M strain. 3. The production method according to claim 1, wherein the carbohydrate is glucose, sorbitol, arabinose, xylose, fructose, inositol, rhamnose, mannitol, acetic acid, succinic acid, or citric acid. 4. The production method according to claim 1, wherein the amino acids are L-glutamic acid, L-aspartic acid, glycine, L-threonine, L-tyrosine, L-isoleucine, and L-proline. 5. The production method according to claim 1, wherein the inorganic metal salt is an inorganic metal salt containing sulfuric acid, magnesium, or manganese. 6. The fatty acid or its derivative is n-heptadecanoic acid, n
- from the group consisting of hexadecanoic acid, n-pentadecanoic acid, n-tetradecanoic acid, or their methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-heptyl, n-hexyl esters; The manufacturing method according to claim 1, which is selected.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62300057A JPH01144982A (en) | 1987-11-30 | 1987-11-30 | Production of unsaturated fatty acid and derivative thereof |
EP88308091A EP0319123B1 (en) | 1987-11-30 | 1988-09-01 | Process for producing unsaturated fatty acid or unsaturated hydrocarbon |
DE3853807T DE3853807T2 (en) | 1987-11-30 | 1988-09-01 | Process for the production of unsaturated fatty acids or unsaturated hydrocarbons. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62300057A JPH01144982A (en) | 1987-11-30 | 1987-11-30 | Production of unsaturated fatty acid and derivative thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01144982A true JPH01144982A (en) | 1989-06-07 |
JPH0412718B2 JPH0412718B2 (en) | 1992-03-05 |
Family
ID=17880179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62300057A Granted JPH01144982A (en) | 1987-11-30 | 1987-11-30 | Production of unsaturated fatty acid and derivative thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01144982A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112424338A (en) | 2018-07-17 | 2021-02-26 | 科纳根公司 | Biosynthetic production of gamma-lactones |
-
1987
- 1987-11-30 JP JP62300057A patent/JPH01144982A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0412718B2 (en) | 1992-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3307095A1 (en) | MICROBIOLOGICALLY PRODUCED L-PHENYLALANINE DEHYDROGENASE, METHOD FOR THEIR DETERMINATION AND THEIR USE | |
JPH01277495A (en) | Biological conversion of l-thirosine and l-phenylalanin to 2, 5-dihydroxyphenyl acetic acid | |
US4840907A (en) | Process for producing optically active dichloropropanol using microorganism | |
DE3247703C2 (en) | Process for the production of L-threonine | |
JPH01144982A (en) | Production of unsaturated fatty acid and derivative thereof | |
EP0089039B1 (en) | Process for producing d-beta-hydroxyalkanoic acid | |
EP0319123B1 (en) | Process for producing unsaturated fatty acid or unsaturated hydrocarbon | |
EP0434393A2 (en) | Process for preparation of R-(-)-3-halogeno-1,2-propanediol by treatment with microorganism | |
DE69839248T2 (en) | PROCESS FOR THE PREPARATION OF INHIBITORS OF HMG-CoA REDUCTASE. | |
US4613571A (en) | Polyprenyl sulfone derivatives and process for producing the same | |
JPS63202392A (en) | Production of unsaturated fatty acid and derivative thereof | |
FR2620731A1 (en) | NOVEL ENZYMATIC SYSTEM, PROCESS FOR PREPARING SAME AND APPLICATION IN PARTICULAR FOR THE PREPARATION OF D-PARAHYDROXYPHENYLGLYCIN | |
Sambale et al. | Microbial hydrolysis of amino acid carbamates | |
JP2991395B2 (en) | 5-Aminolevulinic acid-producing microorganism and method for producing 5-aminolevulinic acid | |
FR2566425A1 (en) | PROCESS FOR THE PRODUCTION OF 2- (PHENYL SUBSTITUTED) PROPIONIC ACID BY MICROORGANISM | |
US4468459A (en) | Process for the preparation of polyprenyl ketone derivatives | |
JP3010850B2 (en) | Process for producing (S)-(+)-3-halo-1,2-propanediol and / or (S)-(-)-2,3-dihalo-1-propanol | |
KR100260837B1 (en) | Optical activating carbon acid and method for preparing isomer ester | |
JPH01144983A (en) | Production of unsaturated hydrocarbon and derivative thereof | |
JPH0559718B2 (en) | ||
JP2797295B2 (en) | Novel microorganism and method for producing menaquinone-4 using the novel microorganism | |
FR2555198A1 (en) | METHOD FOR ENHANCING A MICROORGANISM STRAIN FOR THE PREPARATION OF L-SERINE BY FERMENTATION AND THE STRAIN OBTAINED | |
JPH08196288A (en) | Production of long-chain fatty acid | |
WO1987005329A1 (en) | Process for the separation of racemates | |
JPS6316119B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |